Regencell Bioscience Holdings Ltd Capital Reinvestment Ratio
Regencell Bioscience Holdings Ltd capital reinvestment ratio. Regencell Bioscience Holdings Ltd (RGC) has a Capital Reinvestment Ratio of 0.49x as of December 2017, meaning it reinvests 0% of its operating cash flow ($154.30 Million) in capital expenditures ($74.90 Million). Check Regencell Bioscience Holdings Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Regencell Bioscience Holdings Ltd (2010–2018)
Capital reinvestment ratio of Regencell Bioscience Holdings Ltd from 2010 to 2018. This chart tracks Regencell Bioscience Holdings Ltd's Capital Reinvestment Ratio across 9 annual periods. Also explore Regencell Bioscience Holdings Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Regencell Bioscience Holdings Ltd Capital Reinvestment Ratio by Year (2010–2018)
Regencell Bioscience Holdings Ltd capital reinvestment ratio by year from 2010 to 2018. For the full cash flow conversion analysis, see Regencell Bioscience Holdings Ltd cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.61x | $409.90 Million | $250.40 Million | ▲ +16.7% |
| 2017 | 0.52x | $410.50 Million | $214.90 Million | ▲ +22.5% |
| 2016 | 0.43x | $434.40 Million | $185.70 Million | ▼ -4.8% |
| 2015 | 0.45x | $349.10 Million | $156.80 Million | ▲ +39.0% |
| 2014 | 0.32x | $346.90 Million | $112.10 Million | ▲ +25.6% |
| 2013 | 0.26x | $346.60 Million | $89.20 Million | ▲ +4.2% |
| 2012 | 0.25x | $353.10 Million | $87.20 Million | ▼ -34.9% |
| 2011 | 0.38x | $259.40 Million | $98.40 Million | ▲ +43.2% |
| 2010 | 0.26x | $410.80 Million | $108.80 Million | — |